R. Finlayson

发表

A longitudinal evaluation of Treponema pallidum PCR testing in early syphilis

R. Guy, B. Donovan, N. Jeoffreys, 2012, BMC Infectious Diseases.

Safety and Efficacy of Autologous CD34+ Hematopoietic Progenitor Cells Transduced with an Anti-Tat Ribozyme in a Multi-Center, Randomized, Placebo-Controlled, Phase II Gene Therapy Trial for the Human Immunodeficiency Virus

C. von Kalle, T. Merigan, M. Winters, 2009, Nature Medicine.

B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDS

J. Kaldor, D. Cooper, M. Law, 2000, AIDS.

Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study

Sally S Bebawy, Richard D Moore, J. Margolick, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Hip Structural Parameters over 96 Weeks in HIV-Infected Adults Switching Treatment to Tenofovir-Emtricitabine or Abacavir-Lamivudine

Dominic Michael Dwyer, S. Emery, J. Amin, 2014, PloS one.

Safety and efficacy of nandrolone decanoate for treatment of wasting in patients with HIV infection

J. Gold, B. Allen, N. Bodsworth, 1996, AIDS.

Evolocumab in HIV-Infected Patients With Dyslipidemia

Paul D. Thompson, S. Trottier, C. Fichtenbaum, 2020, Journal of the American College of Cardiology.

Predicts Viral Load OutcomePositive Individuals - Epitope in HLA-B*27 HIV Immune Escape at an Immunodominant

J. Kaldor, D. Cooper, M. Davenport, 2010 .

HIV Infection in Sexually Transmissible Disease Practice in Sydney: The Effects of Legislation, Public Education and Changing Clinical Spectrum

M. Nelson, B. Donovan, R. Finlayson, 1990, International journal of STD & AIDS.

Funding antiretroviral treatment for HIV-positive temporary residents in Australia prevents transmission and is inexpensive.

M. Law, K. Petoumenos, J. Hoy, 2017, Sexual health.

Immunodominant Epitopes in Herpes Simplex Virus Type 2 Glycoprotein D Are Recognized by CD4 Lymphocytes from Both HSV-1 and HSV-2 Seropositive Subjects1

J. Sidney, A. Sette, R. Khanna, 2008, The Journal of Immunology.

HSV-1 and HSV-2 Seropositive Subjects Recognized by CD4 Lymphocytes from Both Simplex Virus Type 2 Glycoprotein D Are Immunodominant Epitopes in Herpes

Rajiv, J. Sidney, A. Sette, 2008 .

No significant effect of uridine or pravastatin treatment for HIV lipoatrophy in men who have ceased thymidine analogue nucleoside reverse transcriptase inhibitor therapy: a randomized trial *

H. Wand, A. Calmy, C. Delhumeau, 2010, HIV medicine.

Spontaneous arterial disease in exotic animals

R. Finlayson, 1965 .

NKT cell depletion in humans during early HIV infection

C. Fernandez, S. Kent, A. Kelleher, 2014, Immunology and cell biology.

Patterns and correlates of hepatitis C virus phylogenetic clustering among people living with HIV in Australia in the direct‐acting antiviral era: A molecular epidemiology study among participants in the CEASE cohort

P. Read, M. Hellard, G. Dore, 2022, Health science reports.

Giant-cell Arteritis of the Legs

J. Robinson, R. Finlayson, 1955, British medical journal.

Patterns and causes of suboptimal response to tenofovir-based therapy in individuals coinfected with HIV and hepatitis B virus.

S. Lewin, K. Ruxrungtham, C. Thio, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study.

D. Cooper, R. Guy, P. Read, 2018, The lancet. HIV.

Enzyme Biochemistry of the Arterial Wall.

R. Finlayson, 1969 .

Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells.

Christof von Kalle, Roger Garsia, Robert Finlayson, 2009, Nature medicine.

Invasive squamous cell carcinoma arising in refractory perianal Bowen's disease in a HIV‐positive individual

D. Damian, R. Finlayson, M. Whitfeld, 2006, The Australasian journal of dermatology.

Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

B. Gazzard, K. Tashima, M. Shields, 2019, The Lancet.

Malignant melanoma associated with human immunodeficiency virus infection in three homosexual men.

D. Cooper, F. Billson, B. Tindall, 1989, Journal of the American Academy of Dermatology.

Efavirenz-associated podocyte damage.

T. Furlong, R. Finlayson, T. Barbour, 2007, AIDS (London).

Factors Associated with Elevated ALT in an International HIV/HBV Co-Infected Cohort on Long-Term HAART

S. Lewin, K. Ruxrungtham, C. Thio, 2011, PloS one.

ACUTE AIDS RETROVIRUS INFECTION Definition of a Clinical Illness Associated with Seroconversion

J. Gold, B. Donovan, DavidA. Cooper, 1985, The Lancet.

Novel deletion of HIV type 1 reverse transcriptase residue 69 conferring selective high-level resistance to nevirapine.

D. Cooper, A. Kelleher, J. Zaunders, 2001, AIDS research and human retroviruses.

The extent of HIV-1-related immunodeficiency and age predict the long-term CD4 T lymphocyte response to potent antiretroviral therapy

D. Cooper, J. Zaunders, M. Bloch, 2002, AIDS.

Infection of CD127+ (Interleukin-7 Receptor+) CD4+ Cells and Overexpression of CTLA-4 Are Linked to Loss of Antigen-Specific CD4 T Cells during Primary Human Immunodeficiency Virus Type 1 Infection

E. Rosenberg, B. Walker, J. Kaldor, 2006, Journal of Virology.

Early Diagnosis of Arthritis of the Hand

R. Finlayson, E. Kauffmann, 1960, Annals of the rheumatic diseases.

Atherosclerosis: A Comparative Study

C. Symons, R. Finlayson, R. T-W-Fiennes, 1962, British medical journal.

HIV Immune Escape at an Immunodominant Epitope in HLA-B*27–Positive Individuals Predicts Viral Load Outcome

J. Kaldor, D. Cooper, M. Davenport, 2011, The Journal of Immunology.

DAA treatment scale-up in HIV/HCV co-infection: characterisinga population at risk for reinfection

M. Hellard, G. Dore, M. Bloch, 2017 .

O7 Moving towards HCV elimination in HIV/HCV co- infection in Australia following universal access to interferon-free therapy

M. Hellard, G. Dore, M. Bloch, 2017 .

Rates of combination antiretroviral treatment change in Australia, 1997–2000

C. Moore, S. Mallal, D. Cooper, 2002 .

Moving towards hepatitis C micro-elimination among people living with HIV in Australia: the CEASE study.

P. Read, M. Hellard, G. Dore, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Low hepatitis C virus reinfection rate despite ongoing risk following universal access to direct-acting antiviral therapy among people living with HIV.

P. Read, M. Hellard, G. Dore, 2020, AIDS.

Primary infection with zidovudine-resistant human immunodeficiency virus type 1 does not adversely affect outcome at 1 year. Sydney Primary HIV Infection Study Group.

J. Kaldor, D. Cooper, C. Duncombe, 1996, The Journal of infectious diseases.

Exocrine pancreatic disease of snakes

I. Doniach, R. Finlayson, S. J. Woods, 2009 .

The microRNA‐9/B‐lymphocyte‐induced maturation protein‐1/IL‐2 axis is differentially regulated in progressive HIV infection

D. Cooper, A. Kelleher, J. Zaunders, 2013, European journal of immunology.

Long-term protection from HIV infection with oral HIV pre-exposure prophylaxis in gay and bisexual men: findings from the expanded and extended EPIC-NSW prospective implementation study.

David Bruce Lewis, R. Guy, P. Read, 2021, The lancet. HIV.

Real-world trends in incidence of bacterial sexually transmissible infections among gay and bisexual men using HIV pre-exposure prophylaxis (PrEP) in Australia following nationwide PrEP implementation: an analysis of sentinel surveillance data.

R. Guy, A. McNulty, M. Hellard, 2022, The Lancet. Infectious diseases.

Assessing the Impacts of Integrated Decision Support Software on Sexual Orientation Recording, Comprehensive Sexual Health Testing, and Detection of Infections Among Gay and Bisexual Men Attending General Practice: Observational Study

J. Kaldor, R. Guy, H. Wand, 2018, JMIR medical informatics.

The rise of targeted HIV oral rapid testing in Australia

P. Read, D. Chan, R. Finlayson, 2015, The Medical journal of Australia.

A Phylogenetic Analysis of Human Immunodeficiency Virus Type 1 Sequences in Kiev: Findings Among Key Populations

C. Morrison, P. Vanhems, A. Kamali, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Activation of NK cells by ADCC responses during early HIV infection.

S. Kent, M. Navis, M. Bloch, 2011, Viral immunology.

Recording the sexual orientation of male patients attending general practice.

J. Kaldor, R. Guy, J. Hocking, 2015, Family Practice.

Subsidized optimal ART for HIV-positive temporary residents of Australia improves virological outcomes: results from the Australian HIV Observational Database Temporary Residents Access Study

Stephen T. Wright, M. Law, K. Petoumenos, 2015, Journal of the International AIDS Society.

Spontaneous Arterial Disease in Animals

R. Finlayson, 1983, Journal of the Royal Society of Medicine.

Antiretroviral Use in the CEASE Cohort Study and Implications for Direct-Acting Antiviral Therapy in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection

G. Dore, M. Bloch, M. Martinello, 2016, Open forum infectious diseases.

Early proliferation of CCR5(+) CD38(+++) antigen-specific CD4(+) Th1 effector cells during primary HIV-1 infection.

E. Rosenberg, B. Walker, J. Kaldor, 2005, Blood.

Rosuvastatin vs. protease inhibitor switching for hypercholesterolaemia: a randomized trial

E. Martinez, M. Bloch, J. Hoy, 2016, HIV medicine.

A RENAL LESION IN ASSOCIATION WITH INFLUENZA

R. Finlayson, I. Beswick, 1959, Journal of clinical pathology.

Experimental Atheroma in Budgerigars

R. Finlayson, V. Hirchinson, 1961, Nature.

HIV-1 DNA Is Maintained in Antigen-Specific CD4+ T Cell Subsets in Patients on Long-Term Antiretroviral Therapy Regardless of Recurrent Antigen Exposure.

D. Cooper, A. Leigh Brown, A. Kelleher, 2019, AIDS research and human retroviruses.

Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005.

B. Gazzard, J. Montaner, R. Weber, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The Role of Hydroxyurea in Enhancing the Virologic Control Achieved Through Structured Treatment Interruption in Primary HIV Infection: Final Results From a Randomized Clinical Trial (Pulse)

J. Kaldor, D. Cooper, A. Kelleher, 2006, Journal of acquired immune deficiency syndromes.

CD4 T cell decline following HIV seroconversion in individuals with and without CXCR4-tropic virus

Anne M Johnson, C. Morrison, P. Vanhems, 2017, The Journal of antimicrobial chemotherapy.

A retrospective clinical audit of general practices in Australia to determine the motivation for switch to dolutegravir/abacavir/lamivudine and clinical outcomes

M. Bloch, D. Baker, N. Roth, 2017, International journal of STD & AIDS.

Characterization of the acute clinical illness associated with human immunodeficiency virus infection.

Rodney J. Lovett, D. Cooper, D. Grant, 1988, Archives of internal medicine.

Predictors of CD4 cell recovery following initiation of antiretroviral therapy among HIV‐1 positive patients with well‐estimated dates of seroconversion

C. Morrison, P. Vanhems, A. Kamali, 2017, HIV medicine.

Evolocumab Use in HIV-Infected Patients With Dyslipidemia: Primary Results of the Randomized, Double-blind BEIJERINCK Study.

S. Trottier, C. Fichtenbaum, C. Katlama, 2020, Journal of the American College of Cardiology.

Lipid in the Achilles tendon. A comparative study.

R. Finlayson, S. J. Woods, 1975, Atherosclerosis.

If I have sex with a duck does that make me a drake? The Albion Street (AIDS) Centre, intravenous drug use and “prostitution”

J. Ziegler, A. Cunningham, A. Wodak, 1990, The Medical journal of Australia.

Calcific cardiomyopathy in young camels (Camelus spp.).

R. Finlayson, I. F. Keymer, V. Mantón, 1971, Journal of comparative pathology.